Serum osteoprotegerin as an early marker of chronic kidney disease in hypertensive patients

• Egile Nagusiak: Khaled A Elhefnawy (Egilea), Ezzat M Mohamed (Egilea), Athar M Abou Yousef (Egilea), Abeer A Fikry (Egilea), Hala M Allam (Egilea)
• Formatua: Liburua
• Argitaratua: SpringerOpen, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background Serum osteoprotegerin (OPG) is a marker of cardiovascular disease. The deterioration of renal function in diabetic patients could be predicted by OPG concentrations, and it was suggested that OPG could be used as a risk marker for chronic kidney disease (CKD) in patients with hypertension...